Marcus Lovell Smith - Chief Executive Officer
Lisa Schimmel - Chief Financial Officer
KC Caine - Assistant to the CFO
Lae Phongsavanh - Technical Project Coordinator
Elizabeth Johansen - Director of Product Design and Implementation
Jeremy Schonhorn, PhD - Principal Scientist
John Connelly, PhD - Senior Scientist
W. Matthew Dickerson, PhD - Senior Scientist
Christina Swanson, PhD - Senior Scientist
Komal Sandhu, MS - Research Associate
Michelle Wong, BS - Research Associate
Kendall Milkey, BS - Research Associate
Ginger Abraham-Freel - Director of Quality, Head of Manufacturing
Patrick Hall - Product Engineer
Julie Richardson, BS- Quality Associate
Ryan Schoeplein, BS - Product Engineer
Carmichael Roberts, PhD
General Partner, North Bridge Venture Partners
Marcus Lovell Smith
Chief Executive Officer, Diagnostics For All
George Whitesides, PhD
Woodford L. and Ann A. Flowers University Professor, Harvard University; Co-founder, Director and Chair of the Diagnostics for All Scientific Advisory Board
Chairman, Nano Terra, Inc.
Henrietta Holsman Fore
Chairman of the Board and Chief Executive Officer, Holsman International
William A. Holodnak, MBA
Founder and CEO, Occam Global
Senior Associate Provost and Chief Technology Development Officer, Harvard University
Dr. Hayat Sindi
Founder and CEO, i2 Institute; Member of the Shoura Council; Member of the Scientific Advisory Board to the UN Secretary-General; UNESCO Ambassador for Sciences
Venture Partner, HLM Venture Partners
Frances K. Heller
Trustee, Dana-Farber Cancer Institute; Board of Directors, Zafgen, Inc.; Board of Directors, Affivinax, Inc.
Chief Executive Officer
Marcus is the CEO of Diagnostics For All. Prior to this, Marcus has directly founded and run businesses in environmental services, real estate, utility metering technology, and broadband wireless. Most recently he ran Sensable Technologies (haptics and 3D software) and Microbia Inc (industrial biotechnology). He has an MA in chemistry from Oxford and the Gibbs Prize in Chemistry.
Chief Financial Officer
Lisa Schimmel joined Diagnostics for All (DFA) as CFO in August 2013. She is primarily responsible for the preparation of monthly financial statements, required reports, annual budget, annual audit, support of payroll and oversight of financial controls. Lisa is a CPA and has a wealth of experience in small to medium size non-profits as well as for-profit companies. Prior to joining DFA, she was the Director of Finance and Human Resources at the Rose Fitzgerald Kennedy Greenway Conservancy. Lisa taught financial and managerial accounting at Boston College from 1992 to 2011. While teaching, she also served on several non-profit boards and finance committees. Prior to her teaching experience she was a manager in Arthur Andersen’s Enterprise Group.
Assistant to the CFO
KC joined Diagnostics For All in August 2015. She has a B.A. in Public Health from Brown University and is interested in global health and international development. Prior to joining DFA, KC worked on digital strategy for Article 25, a global health advocacy group based in Boston, MA.
Lae joined Diagnostics for All in April 2015. She has a B.A. in International Studies from Bentley University. Prior to joining DFA, Lae held various positions ranging from administration to finance at Ascion, LLC.
Director of Product Design and Implementation
Elizabeth joined Diagnostics For All in January 2015. Elizabeth is a strategy, design, and technology expert with international development and emerging markets experience and a passion for global health. Currently implementing new, world class medical products for the poor as Director of Design and Implementation at non-profit Diagnostics For All. With a depth in human-centered design for developing countries as former Director of Product Development at Design that Matters and Project Lead at IDEO, Elizabeth has implemented products across medical device, consumer health, and financial industries for clients including Eli Lilly, Target, Pfizer, and Becton Dickinson. Her most recent product launch is Firefly phototherapy now treating newborns with jaundice in ten developing countries. Elizabeth is also a facilitator who teaches design for social impact to hundreds of organizations, from the smallest social enterprise to the largest bank in the world. She holds a B.S. in Engineering from Harvey Mudd College.
Dr. Schonhorn joined Diagnostics for All in April 2012 as a Principal Scientist after nearly 20 years as a developer of commercial RUO and IVD products. Prior to joining DFA, Dr. Schonhorn was a Senior Scientist with Genzyme’s Diagnostics Division. In this role, Dr. Schonhorn was the primary technical lead for the development of an FDA-approved C. difficile toxin A/B immunochromatographic device. He coordinated the activities of a multinational R&D group to develop key raw materials and develop the finished product. Dr. Schonhorn conducted verification/validation studies, and was the principal technical liaison with manufacturing to transfer the device into production. During his tenure, Dr. Schonhorn also contributed to the evaluation of new point of care technologies, and developed prototype assays for novel biomarkers of stroke and kidney injury. Before his most recent role at Genzyme, Dr. Schonhorn worked at Hemagen Diagnostics where he contributed to the development of FDA-approved assays for antiphospholipid syndrome, as well as Genzyme’s Research Products group where he developed numerous ELISA kits and DuoSets for human cytokines and growth factors. Dr. Schonhorn received his B.S. from Carnegie Mellon University, and his Ph.D. from Boston University.
Dr. Connelly joined Diagnostics For All in November 2011 as a Research Scientist. John has a broad background in nanofabrication, molecular and microbiology with more than 10 years of experience in developing nucleic acid and immunological biosensors for pathogen detection. Prior to DFA, Dr. Connelly was a postdoctoral associate in the Baeumner laboratory at Cornell University working on a collaborative project with Rheonix, Inc. As a graduate assistant, his research included the development of bioanalytical methods for waterborne parasites and viruses as well as quantitative assays for clinical markers, namely CD4+ T-cells. Dr. Connelly has a B.S., M.S. and Ph.D. in Biological Engineering with concentrations in pharmacology and food science and technology. He has published six articles in peer-reviewed journals and is a vice-chair of the 2012 Gordon Research Seminar on Bioanalytical Sensors.
Dr. W. Matthew Dickerson joined DFA in May of 2015 as a Senior Scientist. Dr. Dickerson has more than 20 years of experience in the development and optimization of biological assays in the pharmaceutical industry. Previous to joining DFA he was a senior scientist and head of collaborations at BioScale Inc. At BioScale, he was one of the chief architects for the design and development of assays utilizing the AMMP technology for bioanalytical, preclinical and clinical development. His work includes assays for cytokines, inflammatory biomarkers, phosphoproteins, anti-drug antibodies and cell-based assays. Prior to BioScale, Dr. Dickerson was a senior scientist at ILEX Oncology where he focused on the production and development of antibodies for therapeutic development. He has also developed cell-based screening assay for cancer therapeutics which included Tumistatin and Mucin-1. Dr. Dickerson had similar positions at both Genetics Institute and Biotransplant. Dr. Dickerson received his BS in biology at Mary Washington College and PhD in pharmacology at Northeastern University. He has been an invited speaker at major industry conferences and has multiple publications in peer-reviewed journals.
Dr. Swanson joined Diagnostics for All (DFA) as a senior scientist in September 2013. Bringing a wealth of experience in lateral flow assay (LFA) development, she is primarily responsible for the advancement of DFA's nutrition deficiency assay. Dr. Swanson is trained as both an engineer and immunologist, holding a B.S. in Chemical Engineering from Cornell University, a M.Eng. in Biomedical Engineering from Cornell University and a Ph.D. in Immunology from Stanford University. Prior to joining DFA, she completed postdoctoral training and worked as a research bioengineer developing assays for radiation exposure at SRI International. During her time at SRI, she became adept at working with upconverting phosphors and introduced the usage of near-infrared dyes as valuable tools for detection in LFAs. There, Dr. Swanson enjoyed collaborating with the many physical chemists, biologists, computer scientists and engineers working on the projects. She has authored several publications and played a key role in a diversity of inventions and patent applications related to LFAs, micro-filtration and renal denervation.
Kendall grew up in New Hampshire and graduated from the University of New Hampshire in May 2014 with a B.S. in Biomedical Science. Her undergraduate research involved conducting a mutant screen in the Hrabak lab, where she selected and characterized mutant Arabidopsis thaliana plants with novel root growth to better understand signaling during plant root growth. Kendall has also worked as a veterinary technician at an equine veterinary practice.
Komal Sandhu joined DFA in March of 2013 as a Research Associate. Prior to joining DFA, she worked on several projects dealing with Lead Discovery in the area of Oncology and Autoimmune Diseases at EMD Serono. She volunteered in Henry Wortis Lab, and worked on the project Babesiosis. In India, at CSIO (CSIR affliated) she was an intern in the Nanotechnology Department, where she was graded with 'Outstanding' performance while characterizing and uniformly immobilizing antibody on the surface of optical fiber, thereby constructing a fiber optic based immunosensor. She completed her MS in Biotechnology from Northeastern University and BS in Biotechnology from Punjab Technical University, India.
Michelle Wong joined DFA in May 2014 as a Research Associate. Prior to joining DFA, she was a Research Assistant for the Cabodi Research Group at Boston University. The focus of her research was a platform for microfluidic sample preparation, for eventual point-of-care use, as well as the development of its commercial prototype. She graduated from Boston University with a B.S. in Biomedical Engineering.
Director of Quality, Head of Manufacturing
Ms. Abraham-Freel joined Diagnostics For All (DFA) in December 2014 as the manager of Quality Management Systems (QMS). She has over 20 years of relevant experience in Quality System Regulations, Design Controls and Good Manufacturing Practices (GMPs) in Product Development, Manufacturing Operations and Clinical & Regulatory Affairs for medical devices, pharmaceuticals and biologics. She is proficient in all phases of product life cycle development for medical devices, from design concept through commercialization, including technology transfer. She also has nine patents in the US and several publications for her previous work in product development at Organogenesis, Inc. Ginger holds a Bachelor of Science degree in Biology and Chemistry from Stonehill College
Patrick joined Diagnostics For All in March 2015. He is currently working on his undergrad in Mechanical Engineering. Patrick has been involved in multiple Research and Development projects over the years including API (Active Pharmaceutical Ingredient) manufacturing from scale up to Kilo lab through cGMP as well as biomedical device development specifically bioresorbable self-expanding scaffold technology and a reversible implantable device designed to improve mitral valve coaptation.
Julie holds a B.S. in Chemistry from the University of South Carolina where she graduated with Honors from the South Carolina Honors College. Julie also received the Cooper Scholars Award for academic excellence and the CRC Freshman Chemistry Achievement Award for Honors Chemistry. Julie has over four years of industry experience spanning environmental analytical with the US Army Corps of Engineers, process chemistry for a CMO/CRO and most recently, manufacturing sterile, injectable PET-CT drugs in an FDA regulated environment where she also served as Quality Systems Officer.
Ryan joined Diagnostics For All in May 2014. He earned a B.S. in Biomedical Engineering, Cum Laude, from Boston University, in addition to a Public Health minor. His senior design capstone entitled "Automated Blood Sample Deployment and Retraction for Acoustic Tweezing Rheometer" aimed to improve clinical coagulopathy diagnostics. He earned the Ging S. Lee Community Service Award from the B.U. College of Engineering recognizing his involvement with the Biomedical Engineering Society, Global Brigades, Alpha Eta Mu Beta, Alpha Phi Omega, and Alternative Service Breaks, among others.